Dimitri P. Mikhailidis

21.8k total citations · 4 hit papers
372 papers, 14.3k citations indexed

About

Dimitri P. Mikhailidis is a scholar working on Endocrinology, Diabetes and Metabolism, Cardiology and Cardiovascular Medicine and Surgery. According to data from OpenAlex, Dimitri P. Mikhailidis has authored 372 papers receiving a total of 14.3k indexed citations (citations by other indexed papers that have themselves been cited), including 144 papers in Endocrinology, Diabetes and Metabolism, 120 papers in Cardiology and Cardiovascular Medicine and 91 papers in Surgery. Recurrent topics in Dimitri P. Mikhailidis's work include Diabetes, Cardiovascular Risks, and Lipoproteins (58 papers), Liver Disease Diagnosis and Treatment (50 papers) and Lipoproteins and Cardiovascular Health (47 papers). Dimitri P. Mikhailidis is often cited by papers focused on Diabetes, Cardiovascular Risks, and Lipoproteins (58 papers), Liver Disease Diagnosis and Treatment (50 papers) and Lipoproteins and Cardiovascular Health (47 papers). Dimitri P. Mikhailidis collaborates with scholars based in United Kingdom, Greece and United States. Dimitri P. Mikhailidis's co-authors include Niki Katsiki, Vasilios G. Athyros, Asterios Karagiannis, Moses Elisaf, Κωνσταντίνος Τζιόμαλος, Christos S. Mantzoros, Panagiotis Anagnostis, Maciej Banach, Evangelos Liberopoulos and Paresh Dandona and has published in prestigious journals such as Nature, The Lancet and Journal of Biological Chemistry.

In The Last Decade

Dimitri P. Mikhailidis

370 papers receiving 13.8k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

The Pathogenetic Role of Cortisol in the Metabolic Syndrome: A Hypothesis

2009 482 citations Panagiotis Anagnostis, Vasilios G. Athyros et al. profile →
Safety and efficacy of long-term statin treatment for cardiovascular events in patients with coronary heart disease and abnormal liver tests in the Greek Atorvastatin and Coronary Heart Disease Evaluation (GREACE) Study: a post-hoc analysis

2010 477 citations Vasilios G. Athyros, Κωνσταντίνος Τζιόμαλος et al. profile →
Non-alcoholic fatty liver disease and dyslipidemia: An update

2016 422 citations Niki Katsiki, Dimitri P. Mikhailidis et al. profile →
Non-alcoholic fatty liver disease, insulin resistance, metabolic syndrome and their association with vascular risk

2021 198 citations Emir Muzurović, Dimitri P. Mikhailidis et al. profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Dimitri P. Mikhailidis United Kingdom	60	4.6k	3.9k	3.7k	3.2k	2.1k	372	14.3k
Mohammed Saad United States	71	6.3k 1.4×	2.9k 0.8×	3.4k 0.9×	3.7k 1.1×	3.1k 1.5×	197	15.8k
Johan Sundström Sweden	72	3.1k 0.7×	2.3k 0.6×	6.9k 1.9×	2.6k 0.8×	2.8k 1.3×	363	17.0k
Dimitri P. Mikhailidis United Kingdom	59	3.4k 0.7×	1.8k 0.5×	3.4k 0.9×	6.2k 1.9×	1.5k 0.7×	421	14.8k
Dominique Arveiler France	65	4.4k 1.0×	2.0k 0.5×	6.0k 1.6×	2.6k 0.8×	1.6k 0.8×	247	15.7k
Vasilios G. Athyros Greece	54	4.2k 0.9×	2.6k 0.7×	2.7k 0.7×	3.9k 1.2×	1.1k 0.6×	285	10.5k
Raúl D. Santos Brazil	48	3.6k 0.8×	1.9k 0.5×	3.5k 0.9×	5.9k 1.8×	1.6k 0.8×	375	12.8k
Casper G. Schalkwijk Netherlands	77	5.9k 1.3×	3.3k 0.8×	4.4k 1.2×	2.3k 0.7×	4.0k 2.0×	483	21.5k
Frank L.J. Visseren Netherlands	59	3.2k 0.7×	2.8k 0.7×	5.9k 1.6×	4.6k 1.4×	2.1k 1.0×	468	15.4k
Raffaele Marfella Italy	68	6.7k 1.5×	3.8k 1.0×	5.3k 1.4×	2.8k 0.9×	4.4k 2.1×	267	19.8k
Claudio Ferri Italy	60	2.8k 0.6×	1.4k 0.4×	3.5k 1.0×	2.0k 0.6×	2.1k 1.0×	445	13.3k

Countries citing papers authored by Dimitri P. Mikhailidis

Since Specialization

Citations

This map shows the geographic impact of Dimitri P. Mikhailidis's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Dimitri P. Mikhailidis with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Dimitri P. Mikhailidis more than expected).

Fields of papers citing papers by Dimitri P. Mikhailidis

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Dimitri P. Mikhailidis. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Dimitri P. Mikhailidis. The network helps show where Dimitri P. Mikhailidis may publish in the future.

Co-authorship network of co-authors of Dimitri P. Mikhailidis

This figure shows the co-authorship network connecting the top 25 collaborators of Dimitri P. Mikhailidis. A scholar is included among the top collaborators of Dimitri P. Mikhailidis based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Dimitri P. Mikhailidis. Dimitri P. Mikhailidis is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Kokkorakis, Michail, Emir Muzurović, Marlene Chakhtoura, et al.. (2024). Steatotic Liver Disease: Pathophysiology and Emerging Pharmacotherapies. Pharmacological Reviews. 76(3). 454–499. 36 indexed citations

Gaberšček, Simona, Katja Zaletel, Aleš Blinc, et al.. (2023). Thyroid Disorders and Peripheral Arterial Disease. Current Vascular Pharmacology. 22(1). 36–40. 1 indexed citations

Katsiki, Niki, Kalliopi Kotsa, Anca Pantea Stoian, & Dimitri P. Mikhailidis. (2020). Hypoglycaemia and Cardiovascular Disease Risk in Patients with Diabetes. Current Pharmaceutical Design. 26(43). 5637–5649. 11 indexed citations

Katsiki, Niki, Anca Pantea Stoian, Paschalis Steiropoulos, et al.. (2020). Metabolic Syndrome and Abnormal Peri-Organ or Intra-Organ Fat (APIFat) Deposition in Chronic Obstructive Pulmonary Disease: An Overview. Metabolites. 10(11). 465–465. 11 indexed citations

Manolis, Antonis A., Antonis A. Manolis, Theodora A. Manolis, et al.. (2018). Cardiovascular safety of oncologic agents: A double-edged sword even in the era of targeted therapies – part 1. Expert Opinion on Drug Safety. 17(9). 875–892. 10 indexed citations

Σπανός, Κωνσταντίνος, et al.. (2018). Carotid Bifurcation Geometry as Assessed by Ultrasound is Associated with Early Carotid Atherosclerosis. Annals of Vascular Surgery. 51. 207–216. 4 indexed citations

Athyros, Vasilios G., Κωνσταντίνος Τζιόμαλος, Niki Katsiki, et al.. (2013). The Impact of Smoking on Cardiovascular Outcomes and Comorbidities in Statin-treated Patients with Coronary Artery Disease: A Post hoc Analysis of the GREACE Study. Current Vascular Pharmacology. 11(5). 779–784. 14 indexed citations

Koumaras, Charalambos, Theodora Griva, Thomas Gossios, et al.. (2012). Role of Antihypertensive Drugs in Arterial ‘De-Stiffening’ and Central Pulsatile Hemodynamics. American Journal of Cardiovascular Drugs. 12(3). 143–156. 40 indexed citations

Paraskevas, Kosmas I., Dimitri P. Mikhailidis, & Frank J. Veith. (2012). Comparison of the five 2011 guidelines for the treatment of carotid stenosis. Journal of Vascular Surgery. 55(5). 1504–1508. 43 indexed citations

10.

Kolovou, Genovefa, Dimitri P. Mikhailidis, Denis Lairon, et al.. (2011). Assessment and Clinical Relevance of Non-Fasting and Postprandial Triglycerides: An Expert Panel Statement. Current Vascular Pharmacology. 9(3). 258–270. 228 indexed citations

11.

Breimer, Lars H. & Dimitri P. Mikhailidis. (2011). Is Bilirubin a Marker of Vascular Disease and/or Cancer and is it a Potential Therapeutic Target?. Current Pharmaceutical Design. 17(33). 3644–3655. 18 indexed citations

12.

Gasparyan, Armen Yuri, Antonios Stavropoulos‐Kalinoglou, Dimitri P. Mikhailidis, et al.. (2010). The Rationale for Comparative Studies of Accelerated Atherosclerosis in Rheumatic Diseases. Current Vascular Pharmacology. 8(4). 437–449. 78 indexed citations

13.

Katsiki, Niki, Νικόλαος Παπάνας, & Dimitri P. Mikhailidis. (2010). Dapagliflozin: more than just another oral glucose-lowering agent?. Expert Opinion on Investigational Drugs. 19(12). 1581–1589. 35 indexed citations

14.

Paraskevas, Kosmas I., Maria V. Poulakou, Georgios Agrogiannis, et al.. (2008). Association between plasma levels and immunolocalization of cytokines in heart valve lesions: a possible target for treatment?. Expert Opinion on Therapeutic Targets. 12(10). 1209–1215. 19 indexed citations

15.

Τζιόμαλος, Κωνσταντίνος, Vasilios G. Athyros, Asterios Karagiannis, & Dimitri P. Mikhailidis. (2008). Invited commentary Apolipoproteins C-II and C-III and small dense low density lipoprotein: novel risk factors in metabolic syndrome? Commentary on: Theodosios D. Filippatos et al. Small dense LDL cholesterol and apolipoproteins C-II and C-III in non-diabetic obese subjects with metabolic syndrome (Arch Med Sci 2008; 4, 3: 263–269). Archives of Medical Science. 4(3). 270–273. 1 indexed citations

16.

Παπαθανασίου, Αθανάσιος, John Goudevenos, Dimitri P. Mikhailidis, & Alexandros D. Tselepis. (2008). Acute and long-term antiplatelet therapy. Drugs of today. 44(5). 331–331. 3 indexed citations

17.

Athyros, Vasilios G., Emmanuel S. Ganotakis, Ioannis Goudevenos, et al.. (2006). Awareness, treatment and control of the metabolic syndrome and its components: a multicentre Greek study.. PubMed. 46(6). 380–6. 47 indexed citations

18.

Jagroop, I.A., et al.. (1994). Naftidrofuryl inhibits the release of 5-hydroxytryptamine and platelet-derived growth factor from human platelets. Clinica Chimica Acta. 230(2). 157–167. 18 indexed citations

19.

Mikhailidis, Dimitri P., et al.. (1983). Effect of ethanol on vascular prostacyclin (prostaglandin I2) synthesis, platelet aggregation, and platelet thromboxane release.. BMJ. 287(6404). 1495–1498. 149 indexed citations

20.

Mikhailidis, Dimitri P., J.Y. Jeremy, M.A. Barradas, & Paresh Dandona. (1983). Low phospholipid arachidonic acid values in diabetic platelets. BMJ. 286(6369). 979.4–980. 2 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact